{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
city
~63 mi. (México 2000, Mexico, +75 more cities)
facility
Hospital Infantil de Mexico Federico Gomez ( Site 0535)
drug
bleomycin, +9 more drugs
drug type
chemotherapy, +2 more types
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~70 mi. (Salcajá, Guatemala, +144 more cities)
facility
Centro Medico Integral de Cancerologia CEMIC ( Site 0701)
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
city
~88 mi. (Querétaro, Mexico, +84 more cities)
facility
Cancerologia
drug
nivolumab, +1 more drug
drug type
immunotherapy, +1 more type
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
city
~88 mi. (Querétaro, Mexico, +49 more cities)
facility
Investigational Site Number :4840005
condition
Acute Lymphoblastic Leukemia, +2 more conditions
drug
chemotherapy, +1 more drug
drug type
chemotherapy, +1 more type